Christopher Slapak
2021
In 2021, Christopher Slapak earned a total compensation of $590.6K as Chief Medical Officer at Vor Biopharma, a 52% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,593 |
|---|---|
| Salary | $428,012 |
| Other | $12,043 |
| Total | $590,648 |
Slapak received $428K in salary, accounting for 72% of the total pay in 2021.
Slapak also received $150.6K in non-equity incentive plan and $12K in other compensation.
Rankings
In 2021, Christopher Slapak's compensation ranked 10,360th out of 12,415 executives tracked by ExecPay. In other words, Slapak earned more than 16.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,360 out of 12,415 | 17th |
Division Manufacturing | 4,586 out of 5,508 | 17th |
Major group Chemicals And Allied Products | 2,053 out of 2,378 | 14th |
Industry group Drugs | 1,821 out of 2,099 | 13th |
Industry Biological Products, Except Diagnostic Substances | 401 out of 449 | 11th |
Source: SEC filing on April 28, 2022.
Slapak's colleagues
We found three more compensation records of executives who worked with Christopher Slapak at Vor Biopharma in 2021.